Jason Amello is Chief Financial Officer of Candel Therapeutics Inc.
Person profile
Roles
Candel Therapeutics
Chief Financial Officer
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
TScan Therapeutics, Inc.
2 Feb 24
3
TScan Therapeutics, Inc.
2 Feb 24
4
Candel Therapeutics, Inc.
30 Nov 23
4
Candel Therapeutics, Inc.
28 Nov 23
4
Candel Therapeutics, Inc.
2 May 23
4
Acer Therapeutics Inc.
16 Mar 23
4
Candel Therapeutics, Inc.
12 Dec 22
4
Candel Therapeutics, Inc.
30 Nov 22
4
Candel Therapeutics, Inc.
23 Sep 22
3
Candel Therapeutics, Inc.
23 Sep 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Feb 24 | TCRX Tscan Therapeutics | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 5.15 | 750,000 | 3.86 mm | 750,000 |
28 Nov 23 | CADL Candel Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.9 | 20,153 | 18.14 k | 202,009 |
26 Nov 23 | CADL Candel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 125,717 | 0.00 | 222,162 |
28 Apr 23 | CADL Candel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.29 | 90,000 | 116.10 k | 90,000 |